ALOI, MARINA
ALOI, MARINA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Impact of 5‐ASA discontinuation in children with ulcerative colitis on biologic therapy: A propensity score‐matched study
2026 G. D'Arcangelo, L. Scarallo, G. Mancuso, M. Corpino, C. Romano, L. Norsa, S. Arrigo, M. Bramuzzo, M.T. Fioretti, G. Zuin, M.T. Illiceto, P. Lionetti, M. Aloi
Multicenter Real-World Outcomes of Risankizumab in Crohn's Disease: The RESOLVE IG-IBD Study
2026 F. Scaldaferri, F. Di Vincenzo, M. Aloi, M. Ascolani, P. Balestrieri, L. Bertani, C. Bezzio, G. Bodini, F. Bossa, E. Calabrese, R. Cannatelli, F. Caprioli, M. Cappello, M. Cicala, F. D’Amico, S. Danese, A. De Bernardi, F.R. De Filippo, F. Desideri, D. Di Paolo, A. Di Sario, M.C. Fantini, C. Ferracane, S. Festa, G. Fiorino, R. Gabbiadini, A. Geccherle, V. Gerardi, E. Giangreco, A.G. Gravina, L. Laterza, L.R. Lopetuso, I. Marafini, M. Mastronardi, M. Mendolaro, M. Merli, G. Mocci, S. Onali, M.F. Onidi, L. Pastorelli, A. Piagnani, M.B. Principi, D. Pugliese, D.G. Ribaldone, A. Rispo, F. Rizzello, F. Santagata, E.V. Savarino, R. Spagnuolo, A. Tursi, A. Variola, C. Viganò, A. Armuzzi
Reshaping study design for faster extrapolation‐based drug approval in pediatric inflammatory bowel diseases: An ESPGHAN–NASPGHAN position paper
2026 D. Turner, A. Assa, M. Malham, S.Y. Bar‐asher, C. Rayan, J.S. Hyams, H.H. Uhlig, B. Pasternak, D.C. Wilson, H.K. Michel, L. De Ridder, E. Zuckerman, M. Aloi, P. Szitanyi, M.C. Dubinsky, A.M. Griffiths, R. Saldana, J. Martín‐de‐carpi, E. Wine, R.K. Russell, J. Adler, J. Picoraro
Exploring novel biomarkers in pediatric ulcerative colitis: The role of Lipocalin-2, MMP-9, and MMP-9/LCN-2 complex
2026 G. D'Arcangelo, R. Paparella, A. Gravina, F. Tarani, L. Tarani, M. Aloi, C. Petrella
Can liver biopsy be spared for the diagnosis of autoimmune hepatitis in selected children? A multicenter retrospective study
2026 V. Delle Cave, F. Di Dato, P.L. Calvo, M. Pinon, M. Aloi, F. Zucconi, R. Francavilla, E. Rizzitelli, F. Sbravati, P. Alvisi, R. Iorio
Vedolizumab for extraintestinal manifestations in pediatric inflammatory bowel disease: Results from the VedoKids study
2026 G. D'Arcangelo, D. Turner, O. Ledder, E. Orlanski‐meyer, E. Broide, M. Granot, M. Matar, S. Hussey, A. Yerushalmy‐feler, C. Norden, E. Miele, M. Aloi
Intestinal Ultrasound Scan in Acute Severe Ulcerative Colitis in Children: A Multicenter Prospective Study on Behalf of the Porto Inflammatory Bowel Disease Working Group of European Society for Paediatric Gastroenterology Hepatology and Nutrition
2026 L. Scarallo, P. Alvisi, M. Bramuzzo, A. Domanico, J. Kierkus, M. Matar, C. Strisciuglio, J. De Laffolie, I. Broekaert, M. Aloi, M.V. Rodríguez-Belvís, S. Renzo, F. Labriola, L. Tasciotti, G. Dragoni, P. Lionetti
Successful treatment with upadacitinib in concurrent atopic dermatitis, Crohn's disease, alopecia areata, and eosinophilic gastropathy in a pediatric patient
2026 E. Mortato, L.M. Rao, M. Aloi, A. Cioni, E. Matteini, A. Fico, S. Lambiase, R. Gaeta Shumak, L. Bianchi, E. Campione, L. Diluvio
Risks of Undertreatment and Overtreatment in Pediatric Inflammatory Bowel Disease: Navigating the Balance
2026 G. D'Arcangelo, S. Ancona, G. Naspi Catassi, F. Musto, R. Celano, M. Aloi
Disorders of Gut–Brain Interaction like symptoms in Children with Inflammatory Bowel Disease: A Multicenter Prospective Study from the Pediatric IBD Porto Group of the ESPGHAN
2026 M. Martinelli, S. Salomone, C. Strisciuglio, A. Zellos, C. Romano, V. Dipasquale, M. Bramuzzo, S. Lega, M. Aloi, G. D'Arcangelo, M. Velasco Rodríguez-Belvís, A. Colucci, E. Miele, A. Staiano, R. Eleftheria
Real-life durability and risk factors for biologic discontinuation in pediatric inflammatory bowel disease: results from the SIGENP IBD registry
2025 S. Lega, V. Dipasquale, G. D'Arcangelo, L. Scarallo, S. Ancona, F. Fedele, G. Zuin, F. Graziano, L. Norsa, S. Gatti, M.T. Illiceto, E. Felici, M. Corpino, P.M. Pavanello, R. Cozzali, P. Alvisi, A. Pizzol, C. Banzato, F. Penagini, A. Marseglia, S. Faraci, C. Luini, C. Strisciuglio, C. Moretti, M. Martinelli, S. Arrigo, P. Lionetti, M. Aloi, C. Romano, M. Giangreco, M. Bramuzzo
The Impact of Sarcopenia on Clinical Outcomes in Pediatric Crohn’s Disease
2025 G. D'Arcangelo, D. De Mitri, L. Busato, L. Bottino, F. Maccioni, A. Verrino, M. Aloi
Effect of Overweight and Obesity on the Response to Anti-TNF Therapy and Disease Course in Children With IBD
2025 S. Sila, M. Aloi, U. Cucinotta, L. Gianolio, M. Granot, O. Hradsky, S. Hussey, B. Kang, A. Karoliny, K. Kolho, J. De Laffolie, S. Lega, M. Matar, L. Norsa, S. Omiwole, E. Orlanski-Meyer, L. Palomino, P. Rohani, L. Scarallo, M. Sladek, M.H. Sohouli, D. Urlep, A. Yerushalmy-Feler, E. Zifman, I. Hojsak
Management of paediatric ulcerative colitis, part 1: Ambulatory care-An updated evidence-based consensus guideline from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn's and Colitis Organisation
2025 E. Wine, M. Aloi, S. Van Biervliet, J. Bronsky, J.M. Di Carpi, M. Gasparetto, L. Gianolio, H. Gordon, I. Hojsak, A.S. Hudson, S. Hussey, J. Van Limbergen, E. Miele, L. Norsa, O. Olén, G. Pellino, P. Van Rheenen, L. De Ridder, R.K. Russell, D.S. Shouval, E. Trindade, D. Turner, D.C. Wilson, A. Yerushalmy Feler, A. Assa
Pediatric autoimmune gastritis: An international, multicentric study
2025 M.V. Lenti, S. Joudaki, E. Miceli, E. Lahner, S. Massironi, M. Votto, A. Licari, S.M.E. Caimmi, M. Bramuzzo, G. Di Leo, M. Crocco, F. Malerba, R. Francavilla, P. Lionetti, P. Alvisi, R. Panceri, G. Zuin, V. Villanacci, J. Barp, M. Fuoti, S. Oliva, M. Aloi, M. Distante, A. Assa, Y. Dotan, A. Amato, C. Romano, A. Staiano, E. Miele, C. Strisciuglio, M.T. Fioretti, F. Zingone, M. Cananzi, C. De Giacomo, G. Di Nardo, A. Quadrelli, A. Vanoli, M. Paulli, B. Annibale, G. Marseglia, A. Di Sabatino
Whole Food Diet Induces Remission in Children and Young Adults With Mild to Moderate Crohn's Disease and Is More Tolerable Than Exclusive Enteral Nutrition: A Randomized Controlled Trial
2025 Y. Aharoni-Frutkoff, L. Plotkin, D. Pollak, J. Livovsky, G. Focht, R. Lev-Tzion, O. Ledder, A. Assa, D. Yogev, E. Orlanski-Meyer, E. Broide, J. Kierkuś, B. Kang, B. Weiss, M. Aloi, T. Schwerd, D.S. Shouval, M. Bramuzzo, A.M. Griffiths, M. Yassour, D. Turner
Update on pediatric inflammatory bowel diseases epidemiology during SARS-CoV-2 outbreak:data from the Italian society of pediatric gastroenterology, epatology and nutrition registry
2025 P. Alvisi, M. Congiu, L. Scarallo, M. Aloi, C. Romano, D. Dilillo, D. Knafelz, G. Zuin, M. Bramuzzo, L. Norsa, M. Cananzi, M. Pastore, E. Felici, S. Arrigo, G. D'Arcangelo, G.L. Presti, M. Bacchini, V. Cipriani, P. Lionetti
Response to Letter to the Editor: “Prevalence and trend of anemia in children with inflammatory bowel disease”
2025 G. D'Arcangelo, M. Aloi, N. Null
Maintenance treatment with vedolizumab in paediatric inflammatory bowel disease (VEDOKIDS): 54-week outcomes of a multicentre, prospective, cohort study
2025 O. Atia, Z. Shavit-Brunschwig, R. Lev-Tzion, R. Stein, E. Broide, D. Urlep, J. Hyams, B. Weiss, M. Aloi, A. Assa, K. Gerasimidis, B. Nichols, R.K. Russell, D. Turner
Primary sclerosing cholangitis in children with inflammatory bowel disease: An ESPGHAN position paper from the Hepatology Committee and the IBD Porto group
2025 P.F. Van Rheenen, K. Kolho, R.K. Russell, M. Aloi, A. Deganello, S. Hussey, N. Junge, J. De Laffolie, M.R. Deneau, E. Fitzpatrick, A.M. Griffiths, I. Hojsak, E. Nicastro, A. Nita, M. Pakarinen, A. Ricciuto, L. De Ridder, A. Sonzogni, A. Tenca, M. Samyn, G. Indolfi